Company intelligence / Profile preview

Cerba Lancet Africa

Ownership: Private
Employees: ~1900
Development stage: Commercial

Overview

Cerba Lancet Africa operates the largest network of ISO-accredited clinical pathology laboratories in Africa. It provides routine and specialized diagnostic testing for over three million patients annually across more than a dozen countries. The company also supports clinical trials for pharmaceutical companies with a focus on infectious diseases and oncology. Its expansion has been supported by major international partnerships to increase access to high-quality diagnostic services throughout the continent.

Therapeutic areas: OtherOncologyNephrologyInfectious Diseases
Industry: Pathology

Partnerships

International Finance Corporation/World Bank Group & Proparco for funding expansion and COVID response initiativesLocal healthcare providers/hospitalsBarc Lab for central laboratory services in clinical trials context

Beyond the preview

Go deeper on Cerba Lancet Africa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerba Lancet Africa.

Explore the full profile